Sima Rozati is a Dermatology physician affiliated with Johns Hopkins University. OpenAlex indexes 146 publications with 1,160 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Kyowa KirinProgram year202510 paymentsResearch$16,041openpaymentsdata.cms.gov ↗
- KYOWA KIRIN, INC.Program year202510 payments
- Kyowa KirinProgram year202435 paymentsResearch$272,861openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
58.2%Corticosteroid58.2%Triamcinolone Acetonide100%Part D≥22 patientsCancer & immunology
41.8%Nucleoside Metabolic Inhibitor21.8%Fluorouracil100%Part D<11 patientsFolate Analog Metabolic Inhibitor20%Methotrexate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The real‐world application of T‐cell receptor constant beta‐1 chain antibody assay in cutaneous T‐cell lymphoma
British Journal of Haematology
2025 - The Overlapping Clinicopathological Presentations of Pityriasis Lichenoides and Mycosis Fungoides
Journal of Cutaneous Pathology
2025 - Racial differences in mycosis fungoides and Sézary syndrome: A multicenter cohort study
Journal of the American Academy of Dermatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Daniel Laheru, MD
Johns Hopkins University
Demosthenes G. Katritsis
Johns Hopkins University
Tanguy Seiwert, MD
Johns Hopkins University
Evan Lipson, MD
Johns Hopkins University
Robert Modlin, MD
University of California, Los Angeles
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Joel Gelfand, MD
University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”